Table 1 Baseline characteristics of patients initiating urate-lowering therapy

Mean age, years (SD)

Gender, N (% male)

Number of provider visits for gout prior to ULD initiation, mean (SD)*

Number of physician visits for any diagnosis prior to ULD initiation, mean (SD)*

Hospitalization, N (%)*

Number of provider visits for gout after ULD initiation, mean (SD)†

Charlson comorbidity score, mean (SD)

Associated comorbidities, N (%):

   Hypertension

   Dyslipidemia

   Coronary heart disease

   Diabetes mellitus

   Renal insufficiency

   Renal failure

   Peripheral arterial disease

   Nephrolithiasis

Medications associated with gout or difficulty treating gout, N (%):

   Thiazide diuretics

   All diuretics